Shoji Okinaga

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.6K citations

Medicine, Oncology, Pharmacology +13

Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter Is Associated with Susceptibility to Emphysema

Norihiro Yamada, Mutsuo Yamaya, Shoji Okinaga et al. · The American Journal of Human Genetics · 2000 · 571 citations · Full text

Life Sciences, Genetics, Molecular Genetics +8

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)

Akira Inoue, Kunihiko Kobayashi, Makoto Maemondo et al. · Annals of Oncology · 2012 · 554 citations

Medicine, Oncology, Pharmacology +15

First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy

Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui et al. · Journal of Clinical Oncology · 2009 · 516 citations

Medicine, Oncology, Pharmacology +13

The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness

Alison A. Humbles, Bao Lu, Daniel S. Friend et al. · Proceedings of the National Academy of Sciences · 2002 · 388 citations · Full text

Life Sciences, Immunology, Physiology +17